EMEA-002305-PIP01-17

Key facts

Active substance
hydrocortisone (hemisuccinate)
Therapeutic area
Neonatology-Paediactric Intensive care
Decision number
P/0407/2019
PIP number
EMEA-002305-PIP01-17
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Prevention of bronchopulmonary dysplasia
Route(s) of administration
Intravenous use
Contact for public enquiries
Laboratoire Aguettant

E-mail: infoscientifique@aguettant.fr
Tel. +33 478615141

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating